This present review expands that work by showing that GDF15 levels were higher in individuals with most chronic neurodegenerative conditions, and, with the exception of MS, these elevated levels were typically associated with increased disease incidence and severity. The gene discussed is GDF15; the disease is myeloid sarcoma.